REGENXBIO INC (RGNX) Institutional Ownership and Insiders Activity
REGENXBIO INC (RGNX) is widely held by institutional investors, with 161 firms reporting positions valued at approximately $504.60M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $76.64M in RGNX holdings in its latest filing.
Recent insider activity includes 12 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
161
Total Reported Value
$504.60M
Largest Holder
Blackrock, Inc.
Largest Position
$76.64M
Insider Transactions (90d)
12
Latest Filing Quarter
Q2 2026
New Institutional Positions
27
Funds Exiting Positions
42
Top Institutional Owners
View allInvestorReported Balance
- Blackrock, Inc.$76.64M
- Redmile Group, Llc$52.34M
- State Street Corp$35.59M
- Jpmorgan Chase & Co$26.19M
- Vanguard Capital Management Llc$25.25M
Related RGNX Institutional Insights:
- RGNX 13F Institutional Holders
- RGNX Top Institutional Shareholders
- RGNX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- RGNX Insider Trading & SEC Form 4 Activity
- RGNX Articles
- Top Institutional Investor Stock Rankings